Human Dx
PrivateLast Round
Grant
Feb 1, 2017
Total Funding Raised
$920,000
Company Overview
Human Dx operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in February 2017.
Human Dx is a healthcare technology company that has developed an open medical intelligence platform combining collective intelligence from medical professionals with machine learning to improve diagnostic accuracy and clinical reasoning.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Telemedicine, Medical AI
Business Model
Nonprofit or NGO
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Human Dx Comparables
Compare Human Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MEDizzy | 74% | |
| Formedics | 74% | |
| Isabel Healthcare | 73% |
For institutional investors. Book with your work email.
Human Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2017 | ||||
| Grant | Nov 1, 2016 | ||||
| Seed | Dec 1, 2013 | ||||
| Accelerator | Jul 1, 2012 |
For institutional investors. Book with your work email.
Human Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed |
| SV Angel | Seed |
| StartX | Seed |
| Union Square Ventures | Seed |
| Gordon and Betty Moore Foundation | Grant, Seed |
| First Round Capital | Seed |
| Kapor Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 70% MoM, reaching 12.2K.
- Feb 1, 2017
$250K grant from MacArthur Foundation
For institutional investors. Book with your work email.
Human Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Human Dx's valuation, stock price, and market status.
Is Human Dx a public or private company?
Human Dx is a private company.
What is the current stock price of Human Dx?
Human Dx is a private company, so its shares have no public market price. Caplight tracks Human Dx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Human Dx worth (valuation)?
Valuation information for Human Dx is not publicly available.
Can I buy Human Dx stock?
Human Dx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Human Dx's last funding round?
Human Dx's most recent funding round was Grant on February 1, 2017.
Who are the main investors in Human Dx?
Key investors in Human Dx include Andreessen Horowitz, Union Square Ventures.
Will Human Dx IPO soon?
No public IPO plans have been announced for Human Dx.
How can I track Human Dx secondary market activity?
Caplight tracks bids, offers, and trades in Human Dx's shares on secondary markets.